Nanoparticles enhance immune response against cancer in mice

Vanderbilt University researchers have created nanoparticles that enhance the immune response against melanoma and breast cancer in mice. Published in ACS Nano, the study focuses on lipid nanoparticles delivering a nucleic acid that activates the RIG-I pathway, typically used to combat viral infections. This approach shows promise for future human cancer treatments, building on the success of mRNA vaccines.